Greyledge History Timeline

2003 | Dr. Karli joined The Steadman Clinic

2010 | Greyledge Technologies Founded

– CLIA/COLA Compliant, Quality program initiated


– Comprehensive SOP’s, Employee Training Programs, Quality Systems and Protocols


– FDA Registration (No INDA or BLA needed for products)


– Initial Lab Started

2012 | Second Lab Location Started

– cGMP’s established


– Initial US, Europe, Japan and China patents filed

2013 | Website Launched

2014 | Published with Mishra A, et al. (2014) “Efficacy”

The purpose of this publication was to evaluate the clinical value of tendon needling with PRP in patients with chronic tennis elbow compared with an active control group.

View publication

2015 | US Patent #9,164,079 Issued

“Systems for Autologous Biological Therapeutics”

View Patent

2016 | Decision to Launch Nationwide scale-up of Greyledge Technologies

– Hired Theodore T. Sand, PhD as VP of Research and Regulatory Affairs


– Initiated renewal of website


– European Patent EP 2685816 Granted